Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Currently submitted to: JMIR Cardio

Date Submitted: May 22, 2026
Open Peer Review Period: May 25, 2026 - Jul 20, 2026
(closed for review but you can still tweet)

NOTE: This is an unreviewed Preprint

Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).

Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.

Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).

Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.

Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.

Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

MyHEART-DM Score: A Predictive Screening Risk Scoring Tool for Ischemic Heart Disease Among Malaysian Patients with Type 2 Diabetes Mellitus

  • Muhammad Muzzammil Mohamad Salleh; 
  • Sazzli Shahlan Kasim; 
  • Tajul Rosli Razak; 
  • Nazar Mohd Azahar; 
  • Norzaher Ismail; 
  • Mohamad Zuhair Mohamed Yusoff; 
  • Muhammad Hariz ‘Ammar Khebir; 
  • Muhammad Muaz Shahriman Teruna; 
  • Nur Adila Che Rameli; 
  • Muhammad Irfan Mohd Sallehhudin; 
  • Muhamad Syazni Mohamad Asraff; 
  • Nashuha Omar; 
  • Mohamad Rodi Isa

ABSTRACT

Background:

Ischemic heart disease (IHD) remains the leading cause of mortality worldwide, with patients with type 2 diabetes mellitus (T2DM) experiencing substantially increased cardiovascular risk.

Objective:

This study aimed to develop and validate the MyHEART-DM Score, a prognostic screening tool for predicting IHD risk among Malaysian patients with T2DM using real-world registry data.

Methods:

A retrospective cohort study was conducted using data from the National Diabetes Registry (NDR) Johor, Malaysia, from 2020 to 2024. Patients were divided into development (2020–2021), internal validation (2022–2023), and external validation (2024) cohorts. Multivariable logistic regression was used to develop the prognostic model, and weighted scores were generated using a shrinkage approach. Model performance was assessed using discrimination and calibration analyses.

Results:

A total of 11,082, 13,068, and 7,613 patients were included in the development, internal validation, and external validation cohorts, respectively. The final MyHEART-DM Score incorporated 15 prognostic variables and demonstrated moderate but consistent discrimination across all cohorts, with area under the receiver operating characteristic curve values of 0.686, 0.694, and 0.687, respectively. Calibration performance was satisfactory, with calibration intercepts close to 0 and slopes close to 1 across all cohorts. The score stratified patients into low (<20), intermediate (20–40), and high-risk (>40) categories, with progressively higher odds of IHD observed across risk groups.

Conclusions:

The MyHEART-DM Score may serve as a practical tool for IHD risk stratification among Malaysian patients with T2DM in primary care settings and may contribute toward achieving Sustainable Development Goal 3 by supporting early detection and prevention of cardiovascular complications among high-risk populations. Further prospective validation and integration into clinical decision support systems are recommended. Clinical Trial: Not applicable.


 Citation

Please cite as:

Mohamad Salleh MM, Kasim SS, Razak TR, Azahar NM, Ismail N, Mohamed Yusoff MZ, Khebir MHâ, Shahriman Teruna MM, Che Rameli NA, Mohd Sallehhudin MI, Mohamad Asraff MS, Omar N, Isa MR

MyHEART-DM Score: A Predictive Screening Risk Scoring Tool for Ischemic Heart Disease Among Malaysian Patients with Type 2 Diabetes Mellitus

JMIR Preprints. 22/05/2026:102091

DOI: 10.2196/preprints.102091

URL: https://preprints.jmir.org/preprint/102091

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.